Capricor Therapeutics Inc(CAPR)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CAPR Capricor Therapeutics Inc

盘后交易 01-07 18:23:00 EST

26.31

+0.18

+0.69%

盘后26.31

+0.000.00%

17:51 EST

最高26.94	最低25.70	成交量117.68万
今开26.08	昨收26.13	日振幅4.73%
总市值13.61亿	流通市值12.15亿	总股本5,172万
成交额3,094万	换手率2.55%	流通股本4,619万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"CAPR","market":"US","secType":"STK","nameCN":"Capricor Therapeutics Inc","latestPrice":26.31,"timestamp":1767819600000,"preClose":26.13,"halted":0,"volume":1176755,"hourTrading":{"tag":"盘后","latestPrice":26.31,"preClose":26.31,"latestTime":"17:51 EST","volume":10462,"amount":275300.31122,"timestamp":1767826313092},"delay":0,"floatShares":46186899,"shares":51718475,"eps":-1.805542,"marketStatus":"盘后交易","change":0.18,"latestTime":"01-07 18:23:00 EST","open":26.08,"high":26.935,"low":25.7,"amount":30938712.920250002,"amplitude":0.047264,"askPrice":26.8,"askSize":140,"bidPrice":25.3,"bidSize":30,"shortable":3,"etf":0,"ttmEps":-1.805542,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1767834000000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":26.13,"preHourTrading":{"tag":"盘前","latestPrice":26.08,"preClose":26.13,"latestTime":"09:29 EST","volume":148,"amount":3851.512188,"timestamp":1767796199999},"postHourTrading":{"tag":"盘后","latestPrice":26.31,"preClose":26.31,"latestTime":"17:51 EST","volume":10462,"amount":275300.31122,"timestamp":1767826313092},"volumeRatio":0.738362,"impliedVol":0.8742,"impliedVolPercentile":0.072},"requestUrl":"/m/hq/s/CAPR","defaultTab":"news","newsList":[{"id":"1120106831","title":"异动解读 | Capricor Therapeutics夜盘大涨5%，因DMD疗法试验成功及启动股票发行","url":"https://stock-news.laohu8.com/highlight/detail?id=1120106831","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1120106831?lang=zh_cn&edition=full","pubTime":"2025-12-05 09:04","pubTimestamp":1764896688,"startTime":"0","endTime":"0","summary":"Capricor Therapeutics Inc（CAPR）今日夜盘大涨5%，引起了市场的广泛关注。消息面上，该公司宣布其实验性细胞疗法deramiocel在一项晚期试验中成功减缓了杜氏肌营养不良症（DMD）的发展速度。这一积极结果显著提升了投资者对该公司未来前景的信心。此外，Capricor Therapeutics还启动了股票发行计划，尽管未披露具体规模，但公司表示募集资金将用于继续开发和生产候选产品，进一步推动了股价的上涨。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["CAPR"],"gpt_icon":0},{"id":"1118988587","title":"异动解读 | Capricor Therapeutics盘后大涨5.08%，因DMD疗法试验成功并启动股票发行","url":"https://stock-news.laohu8.com/highlight/detail?id=1118988587","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1118988587?lang=zh_cn&edition=full","pubTime":"2025-12-05 05:44","pubTimestamp":1764884678,"startTime":"0","endTime":"0","summary":"Capricor Therapeutics Inc（CAPR）今日盘后股价大涨5.08%，引起了市场的广泛关注。消息面上，该公司宣布其实验性细胞疗法deramiocel在一项晚期试验中成功减缓了杜氏肌营养不良症（DMD）的发展速度。这一积极结果显著提升了投资者对该公司未来前景的信心。此外，Capricor Therapeutics还启动了股票发行计划，尽管未披露具体规模，但公司表示募集资金将用于继续开发和生产候选产品，进一步推动了股价的上涨。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["CAPR"],"gpt_icon":0},{"id":"1156698629","title":"Capricor股价六倍增长至40美元，因肌肉疾病细胞疗法达成晚期试验目标","url":"https://stock-news.laohu8.com/highlight/detail?id=1156698629","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1156698629?lang=zh_cn&edition=full","pubTime":"2025-12-03 22:44","pubTimestamp":1764773053,"startTime":"0","endTime":"0","summary":"Capricor股价六倍增长至40美元，因其肌肉疾病细胞疗法达成晚期试验目标。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"325c9c18f2935f588a39c7d66a8a00d0","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAPR","BK4139"],"gpt_icon":0},{"id":"1116309654","title":"Capricor高管表示Deramiocel可与任何当前已批准、可用或正在临床开发的治疗药物结合使用","url":"https://stock-news.laohu8.com/highlight/detail?id=1116309654","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1116309654?lang=zh_cn&edition=full","pubTime":"2025-12-03 21:37","pubTimestamp":1764769042,"startTime":"0","endTime":"0","summary":"Capricor高管表示Deramiocel可与任何当前已批准、可用或正在临床开发的治疗药物结合使用","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAPR","BK4139"],"gpt_icon":0},{"id":"1177216032","title":"Capricor Therapeutics高管表示公司通过圣地亚哥制造设施的预许可检查","url":"https://stock-news.laohu8.com/highlight/detail?id=1177216032","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1177216032?lang=zh_cn&edition=full","pubTime":"2025-12-03 21:26","pubTimestamp":1764768371,"startTime":"0","endTime":"0","summary":"Capricor Therapeutics高管表示公司通过圣地亚哥制造设施的预许可检查","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CAPR"],"gpt_icon":0},{"id":"1145758240","title":"Capricor Therapeutics宣布Duchenne肌营养不良症治疗药物Deramiocel在Hope-3关键性第三阶段研究中取得积极的顶线结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1145758240","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1145758240?lang=zh_cn&edition=full","pubTime":"2025-12-03 20:21","pubTimestamp":1764764470,"startTime":"0","endTime":"0","summary":"Capricor Therapeutics宣布Duchenne肌营养不良症治疗药物Deramiocel在Hope-3关键性第三阶段研究中取得积极的顶线结果","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"325c9c18f2935f588a39c7d66a8a00d0","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAPR","BK4139"],"gpt_icon":0},{"id":"1196171207","title":"Capricor Therapeutics第三季度每股收益为-0.54美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1196171207","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1196171207?lang=zh_cn&edition=full","pubTime":"2025-11-20 01:20","pubTimestamp":1763572836,"startTime":"0","endTime":"0","summary":"11月10日讯 - Capricor Therapeutics第三季度基本每股收益为-0.54美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAPR","BK4139"],"gpt_icon":0},{"id":"2575496265","title":"Capricor Therapeutics, Inc.盘中异动 股价大跌5.04%报6.73美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2575496265","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575496265?lang=zh_cn&edition=full","pubTime":"2025-10-14 00:04","pubTimestamp":1760371496,"startTime":"0","endTime":"0","summary":"北京时间2025年10月14日00时04分，Capricor Therapeutics, Inc.股票出现异动，股价大幅下跌5.04%。Capricor Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.82%。Capricor Therapeutics, Inc.公司简介：Capricor Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发基于转化细胞和外泌体的治疗方法，用于治疗杜氏肌营养不良症，这是一种罕见的肌肉营养不良症，导致肌肉变性和过早死亡，以及其他医疗需求未得到满足的疾病。Deramiocel目前正在进行治疗杜氏肌营养不良症的3期临床开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251014000456972b9115&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251014000456972b9115&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CAPR","BK4139","BK4007","BK4539"],"gpt_icon":0},{"id":"1192104664","title":"Capricor Therapeutics就杜氏肌营养不良症Deramiocel项目在A类会议后发布监管进展更新","url":"https://stock-news.laohu8.com/highlight/detail?id=1192104664","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1192104664?lang=zh_cn&edition=full","pubTime":"2025-09-25 19:17","pubTimestamp":1758799035,"startTime":"0","endTime":"0","summary":"Capricor Therapeutics就杜氏肌营养不良症Deramiocel项目在A类会议后发布监管进展更新","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CAPR"],"gpt_icon":0},{"id":"2558692532","title":"Capricor Therapeutics, Inc.8月11日成交额为1777.31万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558692532","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558692532?lang=zh_cn&edition=full","pubTime":"2025-08-12 09:33","pubTimestamp":1754962414,"startTime":"0","endTime":"0","summary":"美东时间2025年8月11日，Capricor Therapeutics, Inc.成交额为1777.31万美元，成交额较昨日减少20.31%，当日成交量为223.13万股。Capricor Therapeutics, Inc.于2025年8月11日跌13.84%，报7.82美元，该股过去5个交易日涨1.76%，年初至今跌43.37%，过去60日涨1.89%。Deramiocel目前正在进行治疗杜氏肌营养不良症的3期临床开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812093547a6e08b8f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812093547a6e08b8f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4007","CAPR","BK4139","LENZ"],"gpt_icon":0},{"id":"1165295263","title":"知名疫苗监管者重返FDA，部分生物科技公司盘前下挫","url":"https://stock-news.laohu8.com/highlight/detail?id=1165295263","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1165295263?lang=zh_cn&edition=full","pubTime":"2025-08-11 18:12","pubTimestamp":1754907141,"startTime":"0","endTime":"0","summary":"疫苗和免疫疗法相关股票曾出现下跌。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"f378b42123c17fa480658121fcaf85bc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAPR","REPL","SRPT"],"gpt_icon":0},{"id":"2558050339","title":"Capricor Therapeutics, Inc.8月8日成交额为2230.27万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558050339","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558050339?lang=zh_cn&edition=full","pubTime":"2025-08-09 09:33","pubTimestamp":1754703215,"startTime":"0","endTime":"0","summary":"美东时间2025年8月8日，Capricor Therapeutics, Inc.成交额为2230.27万美元，成交额较昨日增加190.69%，当日成交量为248.39万股。Capricor Therapeutics, Inc.于2025年8月8日涨12.39%，报9.07美元，该股过去5个交易日涨14.81%，年初至今跌34.28%，过去60日涨24.25%。Deramiocel目前正在进行治疗杜氏肌营养不良症的3期临床开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809093340a6dbe244&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809093340a6dbe244&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4539","BK4007","CAPR","BK4139"],"gpt_icon":0},{"id":"2557751504","title":"Capricor Therapeutics, Inc.8月7日成交额为767.23万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557751504","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557751504?lang=zh_cn&edition=full","pubTime":"2025-08-08 09:33","pubTimestamp":1754616795,"startTime":"0","endTime":"0","summary":"美东时间2025年8月7日，Capricor Therapeutics, Inc.成交额为767.23万美元，成交额较昨日增加38.13%，当日成交量为97.04万股。Capricor Therapeutics, Inc.于2025年8月7日涨4.26%，报8.07美元，该股过去5个交易日跌1.34%，年初至今跌41.52%，过去60日涨13.5%。Deramiocel目前正在进行治疗杜氏肌营养不良症的3期临床开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808093621a47c0611&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808093621a47c0611&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","BK4539","LENZ","CAPR"],"gpt_icon":0},{"id":"2557584187","title":"Capricor Therapeutics, Inc.8月6日成交额为555.45万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557584187","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557584187?lang=zh_cn&edition=full","pubTime":"2025-08-07 09:31","pubTimestamp":1754530315,"startTime":"0","endTime":"0","summary":"美东时间2025年8月6日，Capricor Therapeutics, Inc.成交额为555.45万美元，成交额较昨日减少25.88%，当日成交量为72.22万股。Capricor Therapeutics, Inc.于2025年8月6日涨0.91%，报7.74美元，该股过去5个交易日跌5.38%，年初至今跌43.91%，过去60日涨22.08%。Deramiocel目前正在进行治疗杜氏肌营养不良症的3期临床开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807093555a6d79832&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807093555a6d79832&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CAPR","BK4007","BK4539","LENZ"],"gpt_icon":0},{"id":"2557734572","title":"Capricor Therapeutics, Inc.8月5日成交额为749.41万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557734572","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557734572?lang=zh_cn&edition=full","pubTime":"2025-08-06 09:31","pubTimestamp":1754443877,"startTime":"0","endTime":"0","summary":"美东时间2025年8月5日，Capricor Therapeutics, Inc.成交额为749.41万美元，成交额较昨日减少27.06%，当日成交量为98.46万股。Capricor Therapeutics, Inc.于2025年8月5日跌0.13%，报7.67美元，该股过去5个交易日涨13.8%，年初至今跌44.42%，过去60日涨10.04%。Deramiocel目前正在进行治疗杜氏肌营养不良症的3期临床开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806093436a6d57438&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806093436a6d57438&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CAPR","BK4539","BK4139","LENZ"],"gpt_icon":0},{"id":"2557514356","title":"Capricor Therapeutics, Inc.8月4日成交额为1027.50万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557514356","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557514356?lang=zh_cn&edition=full","pubTime":"2025-08-05 09:30","pubTimestamp":1754357450,"startTime":"0","endTime":"0","summary":"美东时间2025年8月4日，Capricor Therapeutics, Inc.成交额为1027.50万美元，成交额较昨日减少28.49%，当日成交量为137.55万股。Capricor Therapeutics, Inc.于2025年8月4日跌2.78%，报7.68美元，该股过去5个交易日涨13.11%，年初至今跌44.35%，过去60日涨11.47%。Deramiocel目前正在进行治疗杜氏肌营养不良症的3期临床开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805093515a4756f3e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805093515a4756f3e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","LENZ","BK4539","CAPR"],"gpt_icon":0},{"id":"2556814568","title":"Capricor Therapeutics, Inc.盘中异动 急速下跌5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2556814568","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556814568?lang=zh_cn&edition=full","pubTime":"2025-08-01 22:01","pubTimestamp":1754056897,"startTime":"0","endTime":"0","summary":"北京时间2025年08月01日22时01分，Capricor Therapeutics, Inc.股票出现波动，股价大幅下跌5.07%。Capricor Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.02%。Capricor Therapeutics, Inc.公司简介：Capricor Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发基于转化细胞和外泌体的治疗方法，用于治疗杜氏肌营养不良症，这是一种罕见的肌肉营养不良症，导致肌肉变性和过早死亡，以及其他医疗需求未得到满足的疾病。Deramiocel目前正在进行治疗杜氏肌营养不良症的3期临床开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801220138a46feddd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801220138a46feddd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","CAPR","BK4539","BK4007"],"gpt_icon":0},{"id":"2555079339","title":"Capricor Therapeutics, Inc.7月30日成交额为4871.43万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555079339","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555079339?lang=zh_cn&edition=full","pubTime":"2025-07-31 09:30","pubTimestamp":1753925443,"startTime":"0","endTime":"0","summary":"美东时间2025年7月30日，Capricor Therapeutics, Inc.成交额为4871.43万美元，成交额较昨日增加257.15%，当日成交量为603.52万股。Capricor Therapeutics, Inc.于2025年7月30日涨21.36%，报8.18美元，该股过去5个交易日涨19.94%，年初至今跌40.72%，过去60日跌31.03%。Deramiocel目前正在进行治疗杜氏肌营养不良症的3期临床开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731093454a6ca8768&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731093454a6ca8768&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CAPR","BK4539","BK4007","LENZ","BK4139"],"gpt_icon":0},{"id":"1191719360","title":"FDA现重大人事变动！部分生物制药股飙升，REPL飙涨逾100%","url":"https://stock-news.laohu8.com/highlight/detail?id=1191719360","media":"智通财经网","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1191719360?lang=zh_cn&edition=full","pubTime":"2025-07-30 23:31","pubTimestamp":1753889491,"startTime":"0","endTime":"0","summary":"可能有助于缓解监管压力。","market":"us","thumbnail":"https://static.tigerbbs.com/bc7ad619aa7e42a7db4703997b65806b","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/bc7ad619aa7e42a7db4703997b65806b"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"df3f0e1d74b88554715c54dc285ed300","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/content/detail/1323856.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"FDA现重大人事变动！部分生物制药股飙升，REPL飙涨逾100%","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["SRPT","REPL","CAPR"],"gpt_icon":0},{"id":"2555028555","title":"美股异动 | FDA出现重大人事变动 部分生物制药公司股价飙升","url":"https://stock-news.laohu8.com/highlight/detail?id=2555028555","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555028555?lang=zh_cn&edition=full","pubTime":"2025-07-30 22:42","pubTimestamp":1753886560,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"df3f0e1d74b88554715c54dc285ed300","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE00BJJMRZ35.SGD","CAPR","BK4585","IE00BJT1NW94.SGD","159646","SRPT","IE0009355771.USD","BK4007","IE0002141913.USD","BK4539","REPL","BK4139","IE00BFTCPJ56.SGD","LENZ","IE00B2B36J28.USD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.capricor.com","stockEarnings":[{"period":"1week","weight":-0.0977},{"period":"1month","weight":-0.0283},{"period":"3month","weight":2.4933},{"period":"6month","weight":1.2921},{"period":"1year","weight":0.742},{"period":"ytd","weight":-0.0946}],"compareEarnings":[{"period":"1week","weight":0.007},{"period":"1month","weight":0.0089},{"period":"3month","weight":0.0278},{"period":"6month","weight":0.1054},{"period":"1year","weight":0.162},{"period":"ytd","weight":0.0145}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Capricor Therapeutics, Inc.在特拉华州注册成立。该公司是一家临床阶段的生物技术公司，专注于开发基于转化细胞和外泌体的疗法，用于治疗Duchenne肌营养不良症（“DMD”），这是一种罕见的导致肌肉退化和过早死亡的肌营养不良症，以及具有高度未满足的医疗需求的疾病。","yearOnYearQuotes":[{"month":1,"riseRate":0.636364,"avgChangeRate":0.139896},{"month":2,"riseRate":0.5,"avgChangeRate":-0.013804},{"month":3,"riseRate":0.5,"avgChangeRate":-0.020487},{"month":4,"riseRate":0.454545,"avgChangeRate":0.454133},{"month":5,"riseRate":0.272727,"avgChangeRate":-0.152616},{"month":6,"riseRate":0.636364,"avgChangeRate":0.035159},{"month":7,"riseRate":0.363636,"avgChangeRate":0.07472},{"month":8,"riseRate":0.545455,"avgChangeRate":0.008533},{"month":9,"riseRate":0.454545,"avgChangeRate":0.348894},{"month":10,"riseRate":0.090909,"avgChangeRate":-0.099314},{"month":11,"riseRate":0.363636,"avgChangeRate":-0.0945},{"month":12,"riseRate":0.181818,"avgChangeRate":0.280594}],"exchange":"NASDAQ","name":"Capricor Therapeutics Inc","nameEN":"Capricor Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.13","shortVersion":"4.35.13","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Capricor Therapeutics Inc(CAPR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Capricor Therapeutics Inc(CAPR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Capricor Therapeutics Inc,CAPR,Capricor Therapeutics Inc股票,Capricor Therapeutics Inc股票老虎,Capricor Therapeutics Inc股票老虎国际,Capricor Therapeutics Inc行情,Capricor Therapeutics Inc股票行情,Capricor Therapeutics Inc股价,Capricor Therapeutics Inc股市,Capricor Therapeutics Inc股票价格,Capricor Therapeutics Inc股票交易,Capricor Therapeutics Inc股票购买,Capricor Therapeutics Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Capricor Therapeutics Inc(CAPR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Capricor Therapeutics Inc(CAPR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}